[68Ga]Ga-DOTA-Bua-CDKi

N/A

Report date: 2025/10/21 15:09:13

NME

Base Information

Drug Name[68Ga]Ga-DOTA-Bua-CDKi

Drug Alias NameGallium[68Ga]Ga-DOTA-Bua-CDKi

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionCyclin-dependent kinase 4 bindersCyclin-dependent kinase 6 binders

TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 6

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesFudan University Shanghai Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesFudan University Shanghai Cancer Center

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A